Abstract:Objective To analyze the diagnostic value of pituitary enhanced magnetic resonance imaging (MRI) in pituitary stalk interruption syndrome and its correlation with pituitary-target gland dysfunction. Methods A total of 86 cases of pituitary stalk interruption syndrome in our hospital were selected as the case group, and 50 healthy children and adolescents were selected as the control group. According to the pituitary MRI findings in the case group, the complete pituitary stalk block was collected as the group A, and the partial pituitary stalk blocking was collected as the group B. The levels of related hormones in group A, group B and control group were compared, and the relationship between MRI findings and pituitary-target gland function damage was analyzed. Results In the case group, there were 4 normal cases in the posterior pituitary (4.65%), 16 smaller volume cases (18.60%), 56 ectopic cases (65.12%), and 10 absent cases (11.63%). The testosterone (T), estradiol (E2), luteinizing hormone (LH) and other sex hormone levels in the group A and group B were significantly lower than those in the control group (all P< 0.05), and the T level of the group A decreased significantly in comparison to the group B (P < 0.05), and there were not statistically significant differences in comparison of other sex hormone levels (all P > 0.05). The cortisol (COR), adrenocorticotropic hormone (ACTH), free thyroxine (FT4), thyroid stimulating hormone (TSH) and other hormone levels in group A were lower than those in the control group and group B (all P < 0.05); the COR and FT4 levels in group B were significantly lower than those in the control group (both P < 0.05), and other hormone levels showed no significant differences (all P > 0.05). The incidence rate of secondary adrenal insufficiency, hypothyroidism and central diabetes insipidus in group A were significantly higher than those in the group B (χ2 = 10.24, 7.35, 9.35, all P < 0.01). Conclusion Enhanced MRI can effectively diagnose the pituitary-target gland function damage in patients with pituitary stalk interruption syndrome, and it is of higher diagnostic value in the evaluation of pituitary function, which is worthy of clinical promotion.